Rare Diseases Related Content
Mental Health Awareness Week: Spotlight on rare disease
Research carried out for the first time by Rare Disease UK indicates almost all patients and carers living with a rare disease have felt anxious, stressed and low
Access to rare disease therapies in Europe
Simone Boselli, Public Affairs Director of EURORDIS shares the fascinating findings of a new position paper that offers a synthesis of their analysis, reflections and perspectives on access to rare disease therapies in Europe today
New treatments for spinal muscular atrophy
SMA Europe e.V. discusses how new treatments for spinal muscular atrophy open up new challenges for European and national institutions
Huntington’s disease – accessing hope
Sorcha McPhillips, Chief Executive of the Huntington’s disease (HD) Association for Northern Ireland, raises awareness of HD and discusses the impact of hope on the community in the face of new treatments
Nurses in Europe codesigning an EU value-based health and social care ecosystem
Dr Paul De Raeve, Secretary-General of the European Federation of Nurses Associations (EFN) provides an in-depth perspective on the extent to which nurses in Europe are codesigning an EU value-based health and social care ecosystem.
EURORDIS Group call for more access to rare disease therapies in Europe
In light of Rare Disease Day, EURORDIS – Rare Diseases Europe and its member organisations, have launched a new position paper today (28th February), to grant patients full access to rare disease therapies across Europe.
Mutation explains why some people are more vulnerable to viral brain infection
One out of every 10,000 people who are exposed to common viruses like herpes simplex or influenza will develop a potentially deadly brain infection, encephalitis
An emerging environmental health concern: Impacts of air pollution on the brain
Anthony S. Wexler and Pamela J. Lein from the University of California share their expert views on the impacts of air pollution on the brain
Air pollution is a complex mixture of gases and particles in the atmosphere. Air pollutants are defined as compounds known to be deleterious to human...
Moving towards clinical applications of genomics (The TrainMALTA project)
Rosienne Farrugia from the University of Malta explores the role of high throughput sequencing (HTS) in rare and complex diseases, including the move towards the clinical applications of genomics
High throughput sequencing (HTS) is poised to play an ever increasingly central role in the elucidation of the causes of both...
The provision of effective cross-border healthcare
Professor Ruth Ladenstein from SIOPE (the European Society for Paediatric Oncology) discusses how ERN PaedCan facilitates effective cross-border healthcare
The European Commission launched 24 different networks to bring together experts from across the EU to tackle rare diseases by improving diagnosis, treatment and access to specialist care. These are known...
Modern research into rare diseases
Research infrastructure project manager at EURORDIS, Virginie Bros-Facer highlights the extent of rare diseases in Europe in this insightful article
Health officials pledge to reduce cholera deaths by 90%
Health Officials from across the globe are set to meet in France and pledge to dramatically reduce cholera deaths by 2030
The impact of clinical research in rare diseases
Kit C.B. Roes from the University Medical Centre, Utrecht outlines why clinical research in rare diseases requires swift implementation of new methodology
